Press Release
Likarda Receives Grant to Deliver Antibody-Secreting Cell Therapy with CSS® Hydrogel Encapsulation
Grant supports formulation of microcapsules that can protect antibody-producing cells for up to one year in the body Kansas City, MO, March 12,...
Likarda Partners with VitalTE to Develop Extended-Release Injectable Hormone Therapies
Partners will leverage Likarda’s Core-Shell Spherification® platform for slow and steady release of hormones such as testosterone and estradiol with...
Likarda and Cold Chain Technologies Announce Exclusive Partnership to Revolutionize Cell Therapy Material Transportation and Storage
Kansas City, MO and FRANKLIN, MA, Jun 3, 2024 – Likarda, Inc., leading biotech company specializing in the development of enabling technologies for...
Likarda appoints Shelly Adams as Chief Commercial Officer
Kansas City, USA, April 17, 2024 – Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of...
Improving Osteoarthritis Care with Likarda Core Shell Spherification Microbeads
Likarda’s scientists recently published a paper in the journal, Bioengineering, that demonstrates the improved outcomes when stem cells are injected...
Likarda and Evia Bio Announce Novel Tech Cryo Partnership
Kansas City, MO, October 10, 2023 – Likarda, a leader in cell therapy encapsulation for delivery and Evia Bio, a life sciences innovation company...
Likarda Announces Core Shell Spherification for Large Molecule Biologics and Welcomes New CEO, Dr. Stella Vnook
Cambridge, Massachusetts, September 13, 2023 – Likarda, LLC, a pioneering cell therapy company, is at the forefront of creating advanced delivery...
Likarda and eQcell Announce License Option Agreement
Likarda’s Custom Hydrogel Encapsulant to be Used as Cell Therapy Delivery System to Treat Equine Lameness Cambridge, Massachusetts, February 17,...
Search
Categories
Likarda Receives Grant to Deliver Antibody-Secreting Cell Therapy with CSS® Hydrogel Encapsulation
Grant supports formulation of microcapsules that can protect antibody-producing cells for up to...
Likarda Partners with VitalTE to Develop Extended-Release Injectable Hormone Therapies
Partners will leverage Likarda’s Core-Shell Spherification® platform for slow and steady release...
Is Controlled Delivery the Future of Biologics?
Introduction Biologics have emerged as the cornerstone of modern medicine, revolutionizing the...
Don't miss out on new resources!
Get our monthly newsletter